cagrilintide and semaglutide 2.4 mg Safety, tolerability, pharmacokinetics, pharmacodynamics of concomitant administration of multiple doses of with 2·4 for weight management: a randomised, controlled, phase 1b trial Cagrilintide is an amylin analogue

Grateful if you can share this

(Graphic: Business Wire) Hims Hers has been collecting data on access challenges across GLP-1s since the beginning of September

Key Findings: - Increased risk of going over recommended weight gain limits - Higher chances of preterm birth (from 13% to 17%) - Rising cases of gestational diabetes (15% to 20%) - Nearly half faced high blood pressure issues While baby sizes and C-section rates remained similar, the impact on maternal health is significant

however, there is little information on effects on other pancreatic tissues that might be involved in inflammatory processes

A daily multi-strain probiotic designed to support metabolic health and digestive comfort

The world of biochemistry is a complex one, and understanding the various aspects of it can be difficult